MILSAPERIDONE
MILSAPERIDONE is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand name including BYSANTI. Available dosage forms: tablet, kit.
Drug Details
- Generic Name
- MILSAPERIDONE
- Brand Names
- BYSANTI
- Application Number
- NDA220358
- Sponsor
- Vanda Pharmaceuticals Inc.
- NDC Codes
- 16
- Dosage Forms
- TABLET, KIT
- Routes
- ORAL
- Active Ingredients
- MILSAPERIDONE
Indications and Usage
1 INDICATIONS AND USAGE BYSANTI ™ is indicated for the: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ] . Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] . BYSANTI is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 , 14.1 ) Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. ( 1 , 14.2 )